SCHEMBL24598779

SCHEMBL24598779

CC1CCC(NC(=O)c2c(NC(=O)C3CCCC[C@H]3C(=O)O)sc3c2CCC3)CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
RAB9A P51151 1/20 0.62
MAPT P10636 2/20 0.58
HTT P42858 1/20 0.58
REV1 Q9UBZ9 2/20 0.56
FABP4 P15090 9/20 0.51
FABP5 Q01469 9/20 0.51
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TSHR P16473 1/20 0.50
ALOX15 P16050 1/20 0.48
POLB P06746 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
CHD1L Q86WJ1 1/20 0.48
PARP9 Q8IXQ6 1/20 0.48
CASP6 P55212 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20353999 1.00 ALDH1A1 (0.62) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20340298 1.00 ALDH1A1 (0.62) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20339092 0.91 ALDH1A1 (0.67) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20344333 0.89 ALDH1A1 (0.65) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20353887 0.89 ALDH1A1 (0.65) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL21577820 0.87 ALDH1A1 (0.59) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL24426767 0.84 ALDH1A1 (0.60) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL24426732 0.82 ALDH1A1 (0.73) ALDH1A1RAB9AMAPTHTTFABP4
SCHEMBL20353894 0.80 ALDH1A1 (0.53) ALDH1A1RAB9AMAPTHTTFABP4
SCHEMBL29403771 0.80 ALDH1A1 (0.69) ALDH1A1RAB9AMAPTHTTFABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807618-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2023-11-07 US disclosed
US-20220213053-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213053-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS MAVS, EIF2AK2, IRF3 ALDH1A1 3437/4885RAB9A 1661/4885MAPT 3934/4885
US-11807618-B2 Thiophene derivatives as antiviral agents MAVS, EIF2AK2, IRF3 ALDH1A1 3437/4885RAB9A 1661/4885MAPT 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.